Christine Garnett
United States Food and Drug Administration(US)Center for Drug Evaluation and Research(US)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Receptor Mechanisms and Signaling, ECG Monitoring and Analysis, Computational Drug Discovery Methods, Statistical Methods in Clinical Trials
Most-Cited Works
- → Scientific white paper on concentration-QTc modeling(2017)250 cited
- → Concentration‐QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review(2007)218 cited
- → Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase(2015)177 cited
- → Population Pharmacokinetic and Concentration-QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies(2011)168 cited
- → Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions(2011)147 cited
- → Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary(2012)147 cited